Evidence map›Paper›PMID 40581205›Full record

ReviewMolecular and cellular endocrinology2025

Enteroendocrine cell differentiation: Implications for human disease.

Elisa Saint-Denis, Bianca Frintu, Madelyn Goldsmith, Guilherme P Ramos, Daniel Zeve

Abstract readReview
In one paragraph

Review in Molecular and cellular endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Charting Endocrine Progenitors Across Species and Organs.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elisa Saint-DenisDivision of Endocrinology, Boston Children's Hospital, Boston, MA, 02115, USA.
Bianca FrintuDivision of Endocrinology, Boston Children's Hospital, Boston, MA, 02115, USA.
Madelyn GoldsmithDivision of Endocrinology, Boston Children's Hospital, Boston, MA, 02115, USA.
Guilherme P RamosDivision of Endocrinology, Boston Children's Hospital, Boston, MA, 02115, USA; Division of Gastroenterology, Department of Internal Medicine, Mayo Clinic, Phoenix, AZ, 85054, USA. Electronic address: ramos.gui@mayo.edu.
Daniel ZeveDivision of Endocrinology, Boston Children's Hospital, Boston, MA, 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, 02115, USA. Electronic address: daniel.zeve@childrens.harvard.edu.

Funding

Mechanisms mediating human enteroendocrine cell differentiation and functionK08DK134885 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI Daniel Richard Zeve · 2023 to 2026
$673k
NIDDK NIH HHS K08 DK134885
6 · The paper itself

Abstract

Enteroendocrine cells are the most abundant hormone producing cells in humans. Though they make up less than 1 % of the gastrointestinal epithelium, these cells have a large physiological impact through the secretion of hormones that act both locally and systemically to regulate intestinal function and whole-body metabolism, among other functions. The differentiation of enteroendocrine cells from intestinal stem cells is complex, involving not only lineage, but hormonal specification. This review highlights the specific signaling pathways and transcription factors that regulate enteroendocrine cell differentiation and hormone production, integrating newer findings into our growing understanding of this process. Further, it also describes how enteroendocrine cells and their differentiation are involved and altered in human health and disease: specifically aging, inflammatory bowel disease, obesity, and diabetes mellitus. Finally, we focus on how enteroendocrine cells can be targeted to produce insulin, a growing field with significant implications. Understanding what drives enteroendocrine differentiation, both molecularly and physiologically, will provide important insights into how these cells can serve as future therapeutic targets.

Indexed as

Cell DifferentiationEnteroendocrine CellsAnimalsDiabetes MellitusHumansObesitySignal Transduction

Identifiers

PMID40581205
PMCPMC13055164

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.